IP Verse

Reprogramming T Cells And Hematopoietic Cells - EP2548950

The patent EP2548950 was granted to Cellular Dynamics on Oct 25, 2017. The application was originally filed on Jun 4, 2010 under application number EP12177512A. The patent is currently recorded with a legal status of "Revoked".

EP2548950

CELLULAR DYNAMICS
Application Number
EP12177512A
Filing Date
Jun 4, 2010
Status
Revoked
Feb 6, 2024
Grant Date
Oct 25, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREJul 25, 2018GREGSONADMISSIBLE
LONZA WALKERSVILLEJul 25, 2018EDERWITHDRAWN
STRAWMANJul 24, 2018MEWBURN ELLISADMISSIBLE

Patent Citations (45) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20080058858-
DESCRIPTIONUS20080088054-
DESCRIPTIONUS20090156304-
DESCRIPTIONUS20090172079-
DESCRIPTIONEP0045665
DESCRIPTIONEP0273085
DESCRIPTIONUS2003211603
DESCRIPTIONUS2007238170
DESCRIPTIONUS2008038820
DESCRIPTIONUS2008226558
DESCRIPTIONUS2008254003
DESCRIPTIONUS2009047739
DESCRIPTIONUS4683202
DESCRIPTIONUS4684611
DESCRIPTIONUS4952500
DESCRIPTIONUS5302523
DESCRIPTIONUS5322783
DESCRIPTIONUS5384253
DESCRIPTIONUS5464765
DESCRIPTIONUS5538877
DESCRIPTIONUS5538880
DESCRIPTIONUS5550318
DESCRIPTIONUS5563055
DESCRIPTIONUS5580859
DESCRIPTIONUS5589466
DESCRIPTIONUS5591616
DESCRIPTIONUS5610042
DESCRIPTIONUS5656610
DESCRIPTIONUS5702932
DESCRIPTIONUS5736524
DESCRIPTIONUS5780448
DESCRIPTIONUS5789215
DESCRIPTIONUS5925565
DESCRIPTIONUS5928906
DESCRIPTIONUS5935819
DESCRIPTIONUS5945100
DESCRIPTIONUS5981274
DESCRIPTIONUS5994624
DESCRIPTIONWO9409699
DESCRIPTIONWO9503408
DESCRIPTIONWO9506128
DESCRIPTIONWO9920741
OPPOSITIONWO2009032456
OPPOSITIONWO2009149233
OPPOSITIONWO2010141801

Non-Patent Literature (NPL) Citations (156) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AASEN ET AL., NAT. BIOTECHNOL., (2008), vol. 26, pages 1276 - 1284-
DESCRIPTION- AKKINA ET AL., J. VIROL., (1996), vol. 70, pages 2581 - 2585-
DESCRIPTION- ALEXANDER ET AL., PROC. NAT. ACAD. SCI. USA, (1988), vol. 85, pages 5092 - 5096-
DESCRIPTION- ALMQUIST ET AL., MED. CHEM., (1980), vol. 23, no. 12, pages 1392 - 1398-
DESCRIPTION- ANDREWS ET AL., Teratocarcinomas and Embryonic Stem Cells, IRL PRESS, (1987), pages 207 - 246-
DESCRIPTION- BERGER ET AL., BLOOD, (2003), vol. 101, pages 476 - 484-
DESCRIPTION- BISWAS ET AL., Annals NY Acad. Sci., (1990), vol. 590, pages 582 - 583-
DESCRIPTION- BISWAS ET AL., J. CLIN. MICROBIOL., (1991), vol. 29, pages 2228 - 2233-
DESCRIPTION- BODE ET AL., GENE THER. MOL. BIOL., (2001), vol. 6, pages 33 - 46-
DESCRIPTION- BOYER ET AL., CELL, (2005), vol. 122, no. 6, pages 947 - 56-
DESCRIPTION- CARBONELLI ET AL., FEMS MICROBIOL. LETT., (1999), vol. 177, no. 1, pages 75 - 82-
DESCRIPTION- CHADWICK ET AL., BLOOD, (2003), vol. 102, no. 3, pages 906 - 15-
DESCRIPTION- CHAMBERS ET AL., CELL, (2003), vol. 113, no. 5, pages 643 - 55-
DESCRIPTION- CHANDLER ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, no. 8, pages 3596 - 601-
DESCRIPTION- CHATENOUD, CURR. OPIN. IMMUNOL., (2005), vol. 17, pages 632 - 637-
DESCRIPTION- CHEN; OKAYAMA, MOL. CELL BIOL., (1987), vol. 7, no. 8, pages 2745 - 2752-
DESCRIPTION- CHOI ET AL., STEM CELLS, (2009), vol. 27, no. 3, pages 559 - 67-
DESCRIPTION- CHRIST ET AL., HAEMATOLOGICA, (2007), vol. 92, no. 9, pages 1165 - 72-
DESCRIPTION- COCEA, BIOTECHNIQUES, (1997), vol. 23, no. 5, pages 814 - 816-
DESCRIPTION- DONGEN ET AL., LEUKEMIA, (2003), vol. 17, pages 2257 - 2317-
DESCRIPTION- EBERT ET AL., NATURE, (2009), vol. 457, pages 277 - 280-
DESCRIPTION- EMINLI ET AL., NAT. GENET., (2009), vol. 41, pages 968 - 976-
DESCRIPTION- ERCOLANI ET AL., J. RIOL. CHEM., (1988), vol. 263, pages 15335 - 15341-
DESCRIPTION- EVANS ET AL., Cancer Principles and Practice of Oncology, LIPPINCOT-RAVEN, NY, (1997), pages 1054 - 1087-
DESCRIPTION- FECHHEIMER ET AL., PROC NATL. ACAD. SCI. USA, (1987), vol. 84, pages 8463 - 8467-
DESCRIPTION- FELIPE, PROG. BRAIN RES., (2002), vol. 136, pages 215 - 38-
DESCRIPTION- FRALEY ET AL., PROC. NATL. ACAD. SCI. US, (1979), vol. 4, no. 76, pages 3348 - 3352-
DESCRIPTION- GHOSH; BACHHAWAT ET AL., Liver Diseases, Targeted Diagnosis and Therapy Using Specific Receptors and Ligands, MARCEL DEKKER, NY, (1991), pages 87 - 104-
DESCRIPTION- GOPAL, MOL. CELL BIOL., (1985), vol. 5, pages 1188 - 1190-
DESCRIPTION- GRAHAM; DER EB, VIROLOGY, (1973), vol. 52, pages 456 - 467-
DESCRIPTION- GRATWOHL ET AL., BLOOD, (2002), vol. 100, pages 2374 - 2386-
DESCRIPTION- GUO ET AL., STEM CELLS, (2003), vol. 21, no. 1, pages 15 - 20-
DESCRIPTION- HANNA ET AL., CELL, (2008), vol. 133, pages 250 - 264-
DESCRIPTION- HARLAND; WEINTRAUB, J. CELL BIOL., (1985), vol. 101, no. 3, pages 1094 - 1099-
DESCRIPTION- HESS ET AL., BLOOD, (2004), vol. 104, no. 6, pages 1648 - 55-
DESCRIPTION- HONG ET AL., NATURE, (2009), vol. 460, pages 1132 - 1135-
DESCRIPTION- JOHNSON ET AL., BLOOD, (2009), vol. 114, pages 535 - 546-
DESCRIPTION- KADAJA-SAAREPUU ET AL., ONCOGENE, (2008), vol. 27, no. 12, pages 1705 - 15-
DESCRIPTION- KAEPPLER ET AL., PLANT CELL REPORTS, (1990), vol. 9, pages 415 - 418-
DESCRIPTION- KAJI ET AL., NATURE, (2009), vol. 458, pages 771 - 775-
DESCRIPTION- KANEDA ET AL., SCIENCE, (1989), vol. 243, pages 375 - 378-
DESCRIPTION- KARANU ET AL., LEUKEMIA, vol. 17, pages 1366 - 1374-
DESCRIPTION- KARIN ET AL., CELL, (1989), vol. 36, pages 371 - 379-
DESCRIPTION- KATO ET AL., J. BIOL. CHEM., (1991), vol. 266, pages 3361 - 3364-
DESCRIPTION- KAWAMURA ET AL., NATURE, (2009), vol. 460, pages 1140 - 1144-
DESCRIPTION- KIM ET AL., J. VIROL., (1992), vol. 66, pages 3879 - 3882-
DESCRIPTION- KLEEBERGER ET AL., CLIN. DIAGN. LAB IMMUNOL., (1999), vol. 6, pages 14 - 19-
DESCRIPTION- KLEIN ET AL., NATURE, (1987), vol. 327, pages 70 - 73-
DESCRIPTION- LADI ET AL., NATURE IMMUNOLOGY, (2006), vol. 7, pages 338 - 343-
DESCRIPTION- LANGLE-ROUAULT ET AL., J. VIROL., (1998), vol. 72, no. 7, pages 6181 - 6185-
DESCRIPTION- LENT ET AL., J. IMMUNOL., (2007), vol. 179, pages 4959 - 4968-
DESCRIPTION- LEVENSON ET AL., HUM. GENE THER., (1998), vol. 9, no. 8, pages 1233 - 1236-
DESCRIPTION- LEVITSKAYA ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, no. 23, pages 12616 - 12621-
DESCRIPTION- LI ET AL., NATURE, (2009), vol. 460, pages 1136 - 1139-
DESCRIPTION- LOH ET AL., BLOOD, (2009), vol. 113, pages 5476 - 5479-
DESCRIPTION- LUDWIG ET AL., NAT. BIOTECHNOL., (2006), vol. 24, no. 2, pages 185 - 187-
DESCRIPTION- LUDWIG ET AL., NAT. METHODS, (2006), vol. 3, no. 8, pages 637 - 46-
DESCRIPTION- LUDWIG ET AL., NAT. METHODS, (2006), vol. 3, pages 637 - 646-
DESCRIPTION- MACEJAK; SARNOW, NATURE, (1991), vol. 353, pages 90 - 94-
DESCRIPTION- MAHERALI; HOCHEDLINGER, CELL STEM CELL, (2008), vol. 3, pages 595 - 605-
DESCRIPTION- MARION ET AL., NATURE, (2009), vol. 460, pages 1149 - 1153-
DESCRIPTION- MEUER ET AL., CELL, (1984), vol. 36, pages 897 - 906-
DESCRIPTION- MITCHELL ET AL., PLOS BIOL., (2004), vol. 2, page 234-
DESCRIPTION- MORGAN ET AL., SCIENCE, (2006), vol. 314, pages 126 - 129-
DESCRIPTION- NABEL ET AL., SCIENCE, (1989), vol. 244, no. 4910, pages 1342 - 1344-
DESCRIPTION- NARAZAKI ET AL., CIRCULATION, (2008), vol. 118, no. 5, pages 498 - 506-
DESCRIPTION- NG ET AL., BLOOD, (2005), vol. 106, no. 5, pages 1601 - 1603-
DESCRIPTION- NG ET AL., NUC. ACIDS RES., (1989), vol. 17, pages 601 - 615-
DESCRIPTION- NICOLAU ET AL., METHODS ENZYMOL., (1987), vol. 149, pages 157 - 176-
DESCRIPTION- NICOLAU; SENE, BIOCHIM. BIOPHYS. ACTA, (1982), vol. 721, pages 185 - 190-
DESCRIPTION- OMIRULLEH ET AL., PLANT MOL. BIOL., (1993), vol. 21, no. 3, pages 415 - 428-
DESCRIPTION- O'SHCA ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, page 10306-
DESCRIPTION- PELLETIER; SONENBERG, NATURE, (1988), vol. 334, no. 6180, pages 320 - 325-
DESCRIPTION- PERALES ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 4086 - 4090-
DESCRIPTION- POTRYKUS ET AL., MOL. GEN. GENET., (1985), vol. 199, no. 2, pages 169 - 177-
DESCRIPTION- POTTER ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 7161 - 7165-
DESCRIPTION- QUITSCHE ET AL., J. BIOL. CHEM., (1989), vol. 264, pages 9539 - 9545-
DESCRIPTION- RICHARDS ET AL., CELL, (1984), vol. 37, pages 263 - 272-
DESCRIPTION- RIPPE ET AL., MOL. CELL BIOL., (1990), vol. 10, pages 689 - 695-
DESCRIPTION- RYAN ET AL., BIOHEMISTRY, (1997), vol. 36, no. 42, pages 12802 - 12813-
DESCRIPTION- SCYMCZAK ET AL., NAT. BIOTECNNOL., (2004), vol. 22, no. 5, pages 589 - 94-
DESCRIPTION- TAKAHASHI ET AL., CELL, (2006), vol. 126, no. 4, pages 663 - 676-
DESCRIPTION- TAKAHASHI ET AL., CELL, (2007), vol. 126, no. 4, pages 663 - 76-
DESCRIPTION- TAKAHASHI ET AL., CELL, (2007), vol. 131, pages 861 - 872-
DESCRIPTION- THOMSON ET AL., SCIENCE, (1998), vol. 282, pages 1145 - 1147-
DESCRIPTION- TUR-KASPA ET AL., MOL. CELL BIOL., (1986), vol. 6, pages 716 - 718-
DESCRIPTION- UTIKAL ET AL., NATURE, (2009), vol. 460, pages 1145 - 1148-
DESCRIPTION- VODYANIK ET AL., BLOOD, (2006), vol. 108, no. 6, pages 2095 - 2105-
DESCRIPTION- WAGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, no. 9, pages 3410 - 3414-
DESCRIPTION- WANG ET AL., NATURE BIOTECHNOLOGY, (2007), vol. 25, no. 3, pages 317 - 318-
DESCRIPTION- WILSON ET AL., NATURE REVIEWS IMMUNOLOGY, (2009), vol. 9, pages 91 - 105-
DESCRIPTION- WILSON ET AL., SCIENCE, (1989), vol. 244, pages 1344 - 1346-
DESCRIPTION- WOLTJEN ET AL., NATURE, (2009), vol. 458, pages 766 - 770-
DESCRIPTION- WONG ET AL., GENE, (1980), vol. 10, pages 87 - 94-
DESCRIPTION- WU; WU, ADV. DRUG DELIVERY REV., (1993), vol. 12, pages 159 - 167-
DESCRIPTION- WU; WU, BIOCHEMISTRY, (1988), vol. 27, pages 887 - 892-
DESCRIPTION- WU; WU, J. BIOL. CHEM., (1987), vol. 262, pages 4429 - 4432-
DESCRIPTION- WYNN, NATURE IMMUNOLOGY, (2005), vol. 6, pages 1069 - 1070-
DESCRIPTION- YAMANAKA ET AL., CELL, (2007), vol. 131, no. 5, pages 861 - 72-
DESCRIPTION- YANG; RUSSELL, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 4144 - 4148-
DESCRIPTION- YE ET AL., BLOOD, (2009), vol. 114, no. 27, pages 5473 - 80-
DESCRIPTION- YU ET AL., SCIENCE, (2007), vol. 318, pages 1917 - 1920-
DESCRIPTION- YU ET AL., SCIENCE, (2009), vol. 324, no. 5928, pages 797 - 801-
DESCRIPTION- ZHANG ET AL., CIRC RES., (2009), vol. 104, no. 4, pages 30 - 41-
DESCRIPTION- ZHANG ET AL., NAT. BIOTECHNOL., (2001), vol. 19, pages 1129 - 1133-
DESCRIPTION- ZHOU ET AL., CELL STEM CELL, (2009), vol. 4, no. 5, pages 381 - 4-
EXAMINATION- SUTHERLAND D R ET AL, "SENSITIVE DETECTION AND ENUMERATION OF CD34+ CELLS IN PERIPHERAL AND CORD BLOOD BY FLOW CYTOMETRY", EXPERIMENTAL HEMATOLOGY, ELSEVIER INC, US, (19940901), vol. 22, no. 10, ISSN 0301-472X, pages 1003 - 1010, XP000561306-
EXAMINATION- J M CROOP ET AL, "Large-scale mobilization and isolation of CD34+ cells from normal donors", BONE MARROW TRANSPLANTATION, (20000101), vol. 26, no. 12, doi:10.1038/sj.bmt.1702720, pages 1271 - 1279, XP055097594
OPPOSITION- "BD Vacutainer® CPT™", (20090000), pages 1 - 7-
OPPOSITION- BONTKES et al., "Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome", Journal of Leukocyte Biology, (20020000), vol. 72, pages 321 - 329, XP002990425-
OPPOSITION- DE WYNTER, "Comparison of Purity and Enrichment of CD34+ Cells from BoneMarrow, Umbilical Cord and Peripheral Blood (Primed for Apheresis)Using Five Separation Systems", Stem Cells, (19950000), vol. 13, pages 524 - 532, XP002936689-
OPPOSITION- FISCHMEISTER, "G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability", Ann Hematol, (19990000), vol. 78, no. 3, pages 117 - 123, XP055507001-
OPPOSITION- Hirohisa Saito, Et Al.,, "Culture of human mast cells from peripheral blood progenitors", Nature Protocols, (20060000), vol. 1, no. 4, pages 2178 - 2183, XP055506983-
OPPOSITION- Invitrogen Corporation, "Cell concentrations in human and mouse samples", Product Sheet, (20080000), pages 1 - 2, XP055506886-
OPPOSITION- JP MAROLLEAU et al., "Enrichment of peripheral blood CD34 + cells for transplantation usinga fully automated immunomagnetic cell selection system and a noveloctapeptide releasing agent", Bone Marrow Transplantation, (19990000), vol. 23, pages 819 - 826, XP055507005-
OPPOSITION- KOJIMA et al., "Measurement of Endogenous Plasma Granulocyte Colony-Stimulating Factorin Patients With Acquired Aplastic Anemia by a SensitiveChemiluminescent Immunoassay", Blood, (19960000), vol. 87, no. 4, pages 1303 - 1308, XP055507013-
OPPOSITION- Louis M. PELUS, "Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand", PMC ( NIH Public Access Author Manuscript), (20100113), pages 1 - 16, XP055506996-
OPPOSITION- Lvo P Touw,, Marijke Bontenbal, "Granulocyte Colony-Stimulating Factor: Key (F)actor or Innocent Bystander in the Development of Secondary Myeloid Malignancy?", JNCI, (20070000), vol. 99, no. 3, pages 183 - 186, XP055506977-
OPPOSITION- Miltenyi Biotech Inc.,, "Indirect CD 34 MicroBead Kit", Product Sheet, (20080000), pages 1 - 3, XP055506643-
OPPOSITION- "Mobilized Peripheral Blood CD 34+ Stem Progenitor Cells", AIICells.com, pages 1 - 5-
OPPOSITION- NHS Blood and Transplant, "Blood and Transplant Matters", Blood and Transplant Matters, (20090000), no. 29, XP055506927-
OPPOSITION- Nira Varda-Bloom, Tatiana Kniazhansky, Arnon Nagler And Avraham J Treves, "Two Distinct Populations of Enriched Non Mobilized Peripheral Blood Mononuclear Cells (PBMNCs) with Different Functional Capacities", Blood, vol. 112, (20080000), page 5402, URL: http://www.bloodjournal.org/content/112/11/5402?sso-checked=true, XP055507003-
OPPOSITION- Paolo Anderlini, "Effects and safety of granulocyte colony-stimulating factor inhealthy volunteers", PMC (HHS Public Access Author manuscript), (20150603), pages 1 - 11, XP055507008-
OPPOSITION- Sarah Eminli; Adlen Foudi; Matthias Stadtfeld; Nimet Maherali; Tim Ahfeldt; Gustavo Mostoslavsky; Hanno Hock; Konrad Hochedlinger, "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells (Supplementary information)", Nature Genetics,, (20090901), pages 1 - 10, XP055506906-
OPPOSITION- Sarah Eminli; Adlen Foudi; Matthias Stadtfeld; Nimet Maherali; Tim Ahfeldt; Gustavo Mostoslavsky; Hanno Hock; Konrad Hochedlinger, "Differentiation stage determines reprogramming potentail of hematopoietic cells into iPS cells", NIH Public Access Author Manuscript, (20140415), pages 1 - 28, XP055506619-
OPPOSITION- SATO et al., "In Vitro Expansion of Human Peripheral Blood CD34+ Cells", Blood, (19931200), vol. 82, no. 12, pages 3600 - 3609, XP055507026-
OPPOSITION- SOMMER et al., "iPS Cell Generation Using a Single Lentiviral Stem Cell Cassette", PMC/ HHS Public Access Author manuscript/, (20160427), pages 1 - 15, XP055506953-
OPPOSITION- STEMCELL Technologies, "Human Cord Blood CD34+ Cells, Frozen", Product Information Sheet, (20160000), pages 1 - 2, XP055506942-
OPPOSITION- Stemcell Technologies, "StemSpanâ„¢ CC100", Product Information Sheet, (20170000), page 1, XP055506944-
OPPOSITION- STEPHENS M et al., "The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cells harvests", Europe PMC plus, (19961000), URL: https://europepmc.org/abstract/MED/8899194, XP055506632-
OPPOSITION- SUTHERLAND et al., "SENSITIVE DETECTION AND ENUMERATION OF CD34+ CELLS IN PERIPHERAL AND CORD BLOOD BY FLOW CYTOMETRY", EXPERIMENTAL HEMATOLOGY, (19940000), vol. 22, no. 10, pages 1003 - 1010, XP000561306-
OPPOSITION- Tantin, "Oct transcription factors in development and stem cells:insights and mechanisms", Development, (20130000), vol. 140, pages 2857 - 2866, XP055506989-
OPPOSITION- Wai Shun Chan, Andrew L. Pecora, Suzi Nadasi, Lester Myers, Margarita Munoz, Besa Jashari and Robert A. Preti, "Freezing and Cryostorage of Hematopoietic Progenitor Cells (HPC) Apheresis Using 5% Dimethyl Sulfoxide (DMSO) without Hydroxyethyl Starch (HES) in Cryocyte Freezing Bags and in Cryogenic Vials.", Blood, (20060000), vol. 108, no. 11, page 4184, XP055506845-
OPPOSITION- WAKAYAMA et al., "Increased Serum Human Granulocyte Colony-StimulatingFactor (G-CSF) Levels Following Intravenous Infusion ofHigh-Dose Methylprednisolone", Endocrine Journal, (19960000), vol. 43, no. 1, pages 67 - 72, XP055507020-
OPPOSITION- CHIRUMBOLO et al., "Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers", Cytometry Part B (Clinical Cytometry), (20110700), vol. 80B, pages 248 - 253, XP055506938
OPPOSITION- Lefebvre; Dumitriu V; Penzo-Mendez B; Han A; Pallavi Y; B, "Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors", Int J Biochem Cell Biol, (20070000), vol. 39, no. 12, pages 2195 - 2214, XP022277794
OPPOSITION- Moliterno A R; Williams D M; Rogers O; Isaacs M A; Spivak J L, "Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens", Exp. Hemat., (20080000), vol. 36, no. 11, pages 1480 - 1486.e2, XP025587844
OPPOSITION- MOLITERNO et al., "Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens", Exp Hematol., (20080000), vol. 36, no. 11, pages 1480 - 1486.e2, XP025587844
OPPOSITION- MAHERALI NIMET; HOCHEDLINGER K, "Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells", Cell Stem Cell, (20080000), vol. 3, no. 6, pages 595 - 605, XP002532630
OPPOSITION- ZHOU HONGYAN; ET AL, "Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins", Cell Stem Cell, (20090500), vol. 4, no. 5, pages 381 - 384, XP002532629
OPPOSITION- Kabouridis P S, "Biological applications of protein transduction technology", TRENDS IN BIOTECHNOL,, (20030000), vol. 21, no. 11, pages 498 - 503, XP004467497
OPPOSITION- Beaujean F, "Methods of CD34+ cell separation: Comparative analysis", Transfus Sci., (19970000), vol. 18, no. 2, pages 251 - 261, XP004568924
OPPOSITION- EMINLI et al., "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells", NATURE GENETICS, (20090900), vol. 41, no. 9, pages 968 - 976, XP055048798
OPPOSITION- EMINLI et al., "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells", NATURE GENETICS,, (20090901), vol. 41, no. 9, pages 968 - 976, XP055048798
OPPOSITION- YU JUNYING; ET AL, "Human induced pluripotent stem cells free of vector and transgene sequences", Science, (20090000), vol. 324, no. 5928, pages 797 - 801, XP002571323
OPPOSITION- LOH et al., "Generation of induced pluripotent stem cells from human blood", Blood, (20090000), vol. 113, no. 22, pages 5476 - 5479, XP002595207
OPPOSITION- Loh Et Al.,, "Generation of induced pluripotent stem cells from human blood (Supplemental materials)", Blood, vol. 113, no. 22, (20090528), pages 1 - 6, XP055506902
OPPOSITION- LOH YUIN-HAN ET AL, "Generation of induced pluripotent stem cells from human blood", Blood, (20090500), vol. 113, no. 22, pages 5476 - 5479, XP002595207
OPPOSITION- Dan S. KAUFMAN, "Toward Clinical Therapies Utilizing Hematopoietic Cells Derived from Human Pluripotent Stem Cells", Blood, (20091022), vol. 114, no. 17, pages 3513 - 3523, XP055506843
OPPOSITION- YE et al., "Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders", Blood, (20090000), vol. 114, no. 27, pages 5473 - 5480, XP008162340
OPPOSITION- YE et al., "Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders", Blood, (20090000), vol. 114, pages 5473 - 5480, XP008162340
OPPOSITION- Tura Olga; Barclay G Robin; Roddie Huw; Davies John; Turner Marc L, "Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources", Journal of Translational Medicine,, (20070000), vol. 5, page 37, XP021030183
OPPOSITION- BROWN et al., "Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes", PLoS One, (20100600), vol. 5, no. 6, page e11373, 8pp, XP009149252
OPPOSITION- Noemi FUSAKI; Hiroshi BAN; Akiyo NISHIYAMA; Koichi SAEKI; Mamoru HASEGAWA, "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome", Proc. Jpn. Acad. Ser. B, (20090000), vol. 85, pages 348 - 362, XP002663242
SEARCH- SARAH EMINLI ET AL, "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells", NATURE GENETICS, (20090901), vol. 41, no. 9, doi:10.1038/ng.428, ISSN 1061-4036, pages 968 - 976, XP055048798 [XP] 1-12 * the whole document * * page 973, column L, paragraph 1 - column R, paragraph 3 *
SEARCH- LOH YUIN-HAN ET AL, "Generation of induced pluripotent stem cells from human blood", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 113, no. 22, doi:10.1182/BLOOD-2009-02-204800, ISSN 0006-4971, (20090501), pages 5476 - 5479, (20090318), XP002595207 [A] 1-12 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents